Transcription of BENERVA 50MG TABLETS PL 00010/0610 BENERVA 100MG TABLETS ...
{{id}} {{{paragraph}}}
UKPAR BENERVA 50mg & 100MG TABLETS PL 00010 /0610-1 1 BENERVA 50MG TABLETS PL 00010 /0610 BENERVA 100MG TABLETS PL 00010 /0611 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 14 Steps taken after authorisation summary Page 15 Summary of Product Characteristics Page 16 Product Information Leaflet Page 24 Labelling Page 28 UKPAR BENERVA 50mg & 100MG TABLETS PL 00010 /0610-1 BENERVA 50MG TABLETS PL 00010 /0610 BENERVA 100MG TABLETS PL 00010 /0611 LAY SUMMARY The Medicines Healthcare products Regulatory Agency granted Bayer plc Marketing Authorisations (licences) for the medicinal
UKPAR Benerva 50mg & 100mg Tablets PL 00010/0610-1 PHARMACEUTICAL ASSESSMENT DRUG SUBSTANCE Thiamine Hydrochloride Nomenclature
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}